Literature Cited
R. Yu. Il'yuchenok, The Pharmacology of Behavior and Memory [in Russian], Novosibirsk (1972), p. 53.
R. U. Ostrovskaya, G. M. Molodavkin, R. N. Porfir'eva, et al., Byull. Éksp. Biol. Med., No. 3, 50 (1975).
R. A. Agarwal, J. D. Lapierre, R. B. Rastogi, et al., Br. J. Pharmacol.,60, 3 (1977).
B. Biswas and A. Carlsson, Arch. Exp. Path. Pharmak.,299, 41 (1977).
R. B. Baulu, M. Labas, and P. Ngoma-Jengo, C. R. Acad. Sci. (Paris),D-285, 1549 (1977)
H. Corrodi, K. Fuxe, P. Lidbrink, et al., Brain Res.,29, 1 (1971).
E. Costa, A. Guidotti, C. C. Mao, et al., Life Sci.17, 167 (1975).
D. R. Curtis and D. Felix, Brain Res.,34, 301 (1971).
K. S. Killam and J. A. Bain, J. Pharmacol. Exp. Ther.,119, 255 (1957).
K. Kukino and T. Deguchi, Chem. Pharm. Bull.,25, 2257 (1977).
P. Lidbrink, H. Corrodi, K. Fuxe, et al., in: The Benzodiazepines, S. Garattini, E. Mussini, and L. O. Randall, eds., New York (1973), p. 203.
J. Maj, E. Przegalinski, and M. J. Wielosz, J. Pharm. Pharmacol.,20, 247 (1968).
R. D. Rastogi, J. D. Lapierre and R. L. Singhal, Prog. Neuro-Psychopharmacol.,2, 43 (1978).
S. Vellucci and S. E. File, Psychopharmacology,62, 61 (1979).
C. Wise, B. Berger and L. Stein, Science,177, 180 (1972).
Rights and permissions
About this article
Cite this article
Voronina, T.A., Garibova, T.L. Role of GABA-ergic and dopaminergic mechanisms in the development of the “rebound” syndrome after cessation of long-term administration of phenazepam. Bull Exp Biol Med 90, 908–910 (1980). https://doi.org/10.1007/BF00833255
Received:
Issue date:
DOI: https://doi.org/10.1007/BF00833255